Elevated atherogenic index of plasma increased the risk of myocardial infarction in a general population

Ann Epidemiol. 2024 Feb:90:1-8. doi: 10.1016/j.annepidem.2023.11.002. Epub 2023 Nov 17.

Abstract

Purpose: The atherogenic index of plasma (AIP) has been shown to be related to cardiovascular disease risk, but evidence on the longitudinal pattern of AIP during follow-up is limited. We aimed to explore the associations of baseline and long-term AIP with the risk of myocardial infarction (MI).

Methods: We included 98,861 participants in the Kailuan Study who were free of MI at baseline. AIP was calculated as log (triglyceride/high-density lipoprotein cholesterol). Long-term AIP included the long-term mean AIP (mean AIP from baseline to the first occurrence of MI or the end of follow-up) and number of visits with high AIP (above the cutoff value at the first three visits). The baseline and updated mean AIP were in operationalized as quartiles. Cox proportional hazard models were used to determine the associations between AIP and risk of MI. We excluding all deaths during the follow-up visits in the sensitivity analysis.

Results: During a median follow-up of 12.80 years, 1804 participants developed MI. Compared with quartile 1, the adjusted hazard ratios in baseline and updated mean AIP quartile 4 were 1.63 (95% CI, 1.41-1.88) and 1.59 (95% CI, 1.37-1.83), respectively. Compared with participants who did not have a high AIP, the HR among individuals with AIP elevated by three times was 1.94 (95% CI,1.55-2.45). The sensitivity analysis showed similar associations.

Conclusions: Elevated levels of both baseline and long-term AIP increased the risk of MI.

Keywords: Atherogenic index of plasma; Longitudinal pattern; Myocardial infarction; Risk factor.

MeSH terms

  • Cholesterol, HDL
  • Humans
  • Myocardial Infarction* / epidemiology
  • Risk Factors
  • Triglycerides

Substances

  • Triglycerides
  • Cholesterol, HDL